Additional file 1 of Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer

  • Chiara Naro (Creator)
  • Ambra Antonioni (Creator)
  • Vanessa Medici (Creator)
  • Cinzia Caggiano (Creator)
  • Ariane Jolly (Creator)
  • Pierre de la Grange (Creator)
  • Pamela Bielli (Creator)
  • Maria Paola Paronetto (Creator)
  • Claudio Sette (Creator)

Dataset

Description

Additional file 1: Supplementary Table 1. List of drugs used in the study, Supplementary Table 2. List of primers used in this study.
Dati resi disponibili2024
Editorefigshare

Cita questo